USPTO trademark

DEJEVMA

Awaiting publicationUSPTOWord markClass 5

"DEJEVMA" is a word mark owned by Teva Pharmaceuticals USA, Inc., filed at the USPTO on August 4, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).

Official USPTO record
DEJEVMA trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 12, 2026
Filed
August 4, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50030882
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns DEJEVMA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services DEJEVMA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and skin disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Notification of examiners amendment e-mailed
  3. Examiner's amendment entered
  4. Examiners amendment e-mailed
  5. Examiners amendment -written
  6. Assigned to examiner
  7. Application filing receipt mailed
  8. New application office supplied data entered
  9. New application entered
FAQ

About DEJEVMA

Who owns the trademark "DEJEVMA"?

The USPTO trademark "DEJEVMA" (application 50030882) is owned by Teva Pharmaceuticals USA, Inc.

What is the status of "DEJEVMA"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DEJEVMA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019fd20a-e600-74a4-9bd0-ad9498acd604
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019fd20a-e600-74a4-9bd0-ad9498acd604",
  "object": "trademark",
  "mark_text": "DEJEVMA",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "50030882",
  "filing_date": "2026-08-04",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Teva Pharmaceuticals USA, Inc.",
      "entity_id": "ent_019fc41c-ecc5-76e9-863d-e500c53224ec"
    }
  ]
}